Recent Updates
Recently added Catalysts
BCAX Positive Sentiment Score: 80/100

Bicara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Monday, February 24, 2025 1 min read
Key Takeaway: Bicara Therapeutics Inc. will be presenting at the TD Cowen 45th Annual Health Care Conference on March 3, 2025. Claire Mazumdar, the CEO, will lead the presentation, highlighting the company's focus on transformative bifunctional therapies for solid tumors. A live webcast of the event will be available, along with a replay for those unable to attend.

Market Sentiment Analysis

POSITIVE FACTORS

  • Bicara Therapeutics is actively engaging with the investment community.
  • The presentation signifies the company's commitment to innovation in solid tumor therapies.
  • Live webcast access enhances transparency and engagement with stakeholders.

Full Press Release Details

BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that Claire Mazumdar, PhD, MBA, Chief Executive Officer, will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025 at 3:10 p.m. ET.
A live webcast of the presentation will be available at Events and Presentations. A replay of the webcast will be archived and available following the event.
About Bicara Therapeutics

Frequently Asked Questions

When is Bicara Therapeutics presenting at the TD Cowen Conference?

Bicara Therapeutics will present on March 3, 2025, at 3:10 p.m. ET.

Who will present for Bicara Therapeutics at the conference?

Claire Mazumdar, PhD, MBA, will present at the conference.

Where can I watch the presentation live?

The presentation will be available live on the Events and Presentations page.

Will there be a replay available after the presentation?

Yes, a replay of the webcast will be archived post-event.

What is the focus of Bicara Therapeutics?

Bicara Therapeutics focuses on bifunctional therapies for solid tumors.

Tags: BCAX Viatris Investor Conferences Healthcare Bicara Therapeutics health care conference solid tumors biopharmaceuticals
Last updated: Feb 24, 2025